PO.CL08.01 · 临床研究

用于增强光动力和X射线激活癌症治疗的原子级精确NHC稳定型金纳米团簇

Atomically precise NHC-stabilized gold nanoclusters for enhanced photodynamic and X ray activated cancer therapy

海报缩略图:用于增强光动力和X射线激活癌症治疗的原子级精确NHC稳定型金纳米团簇
编号 6626 展板 27 时间 4/21 02:00–05:00 区域 Section 46 主讲 Hetvi Shah, BS;MS
分会场 Radiation and Photodynamic Therapy Response Modifiers
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Hetvi Shah1, Angus Isaac Sullivan2, Juan Chen2, Gang Zheng2

1Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada,2Princess Margaret Cancer Centre, Toronto, ON, Canada

摘要 Abstract

中文摘要
金纳米团簇(AuNCs)是原子级精确、超小(<2 nm)的纳米颗粒,具有良好的生物相容性和肾脏清除特性1-2。N-杂环卡宾(NHC)功能化的金纳米团簇(NHC-AuNCs)是一类新型纳米材料,具有高化学稳定性、结构可调性以及放大辐射诱导细胞毒性的强大潜力3-4。我们合成了双N-杂环卡宾(NHC)保护的Au13纳米团簇,其表现出固有的光致发光量子产率,使其成为癌症诊疗一体化的有吸引力的候选者。我们的目标是通过增强其分布、提高其肿瘤靶向能力,并将其用作光动力治疗和/或放射治疗(RT)的增敏剂,从而改善其治疗性能。在本工作中,我们开发了具有约20-30%活性氧(ROS)生成效率的新型NHC-AuNCs,这是诱导ROS介导的癌细胞DNA损伤的关键特性。我们进行了体外研究,包括细胞毒性、细胞摄取和PDT效力评估,以评估其作为PDT剂的有效性。ICP-MS分析验证了其在多种胰腺癌细胞系中的高效细胞摄取。在10和20 J/cm²的PDT照射下,用5 µM NHC-AuNCs处理诱导了超过90%的细胞死亡,而在未经AuNC处理和未经光照处理的对照组中均观察到可忽略的细胞毒性。这些NHC-AuNCs以先前测试AuNCs一半的浓度即显示出高PDT疗效,使其成为强效的PDT剂。正在进行的工作聚焦于优化纳米团簇框架以增强肿瘤特异性。表面叠氮基团的引入使得能够通过点击化学偶联靶向肽以改善肿瘤靶向。与此同时,评估荷瘤模型中生物分布、PDT疗效和生存结局的体内研究正在进行中,以确立这些NHC稳定型AuNCs的治疗潜力。这些纳米团簇作为强效PDT剂的能力为推进癌症靶向治疗提供了一个强大的纳米平台。将讨论具有不同光物理和化学性质的各种NHC-AuNCs作为PDT剂的能力。 参考文献 [1] Huang, Y 等,Nat. Nanotechnol. 2023, 18 (6), 637-646. [2] Zhang, X.-D. 等,Enhanced Tumor Accumulation of Sub-2 Nm Gold Nanoclusters for Cancer Radiation Therapy. Advanced Healthcare Materials 2014, 3 (1), 133-141. [3] Kulkarni, V. 等,Impact of ligand Structure on Biological Activity and Photophysical Properties of NHC-Protected Au13 Nanoclusters. J. Am. Chem. Soc 2025, 147 (5) 4017-4025. [4] Sullivan, A. 等. Diving into Unknown Waters: Water-Soluble Clickable Au13 Nanoclusters Protected with N-Heterocyclic Carbenes for Bio-Medical Applications. J. Am. Chem. Soc 2025, 147 (5) 4230-4238.
查看英文原文 English abstract
Gold nanoclusters (AuNCs) are atomically precise, ultrasmall (<2 nm) nanoparticles that exhibit favorable biocompatibility and renal clearance properties 1-2 . N-heterocyclic carbene (NHC) functionalized gold nanoclusters (NHC-AuNCs) are a new class of nanomaterials with high chemical stability, structural tunability, and strong potential to amplify radiation-induced cytotoxicity 3-4 . We have synthesized bis-N-heterocyclic carbene (NHC)-protected Au 13 nanoclusters that display intrinsic photoluminescence quantum yields, making them attractive candidates for cancer theranostics. Our objective is to improve their therapeutic performance by enhancing their distribution, increasing their tumor-targeting capability, and employing them as sensitizers for photodynamic therapy and/or radiotherapy (RT). In this work, we developed novel NHC-AuNCs with ~20-30% reactive oxygen species (ROS) production efficiency, a key property for inducing ROS-mediated DNA damage in cancer cells. We performed in vitro studies, including cytotoxicity, cellular uptake, and PDT potency evaluation, to assess their effectiveness as PDT agents. ICP-MS analyses verified efficient cellular uptake across multiple pancreatic cancer cell lines. Upon PDT irradiation at 10 and 20 J/cm 2 , treatment with 5 µM NHC-AuNCs induced over 90% cell death, whereas negligible cytotoxicity was observed in both non-AuNC-treated and no-light-treated control groups. These NHC-AuNCs show high PDT efficacy at half the concentration compared to previously tested AuNCs, making them a potent PDT agent. Ongoing work focuses on refining the nanocluster framework to enhance tumor specificity. The incorporation of surface azide groups enables click-chemistry conjugation of targeting peptides to improve tumour targeting. In parallel, in vivo studies assessing biodistribution, PDT efficacy, and survival outcomes in tumor-bearing models are underway to establish the therapeutic potential of these NHC-stabilized AuNCs.The ability of these nanoclusters to act as potent PDT agents provides a powerful nanoplatform for advancing cancer targeted therapy. The ability of various NHC-AuNCs with different photophysical and chemical properties to act as PDT agents will be discussed. References [1] Huang, Y etc., Nat. Nanotechnol. 2023, 18 (6), 637-646. [2] Zhang, X.-D. etc., Enhanced Tumor Accumulation of Sub-2 Nm Gold Nanoclusters for Cancer Radiation Therapy. Advanced Healthcare Materials 2014, 3 (1), 133-141. [3] Kulkarni, V. etc., Impact of ligand Structure on Biological Activity and Photophysical Properties of NHC-Protected Au13 Nanoclusters. J. Am. Chem. Soc 2025, 147 (5) 4017-4025. [4] Sullivan, A. etc. Diving into Unknown Waters: Water-Soluble Clickable Au13 Nanoclusters Protected with N-Heterocyclic Carbenes for Bio-Medical Applications. J. Am. Chem. Soc 2025, 147 (5) 4230-4238.
利益披露 Disclosure
H. Shah, None.. A. Sullivan, None.. J. Chen, None.. G. Zheng, None.

← 返回 AACR 2026 检索